Suchergebnisse - "Khamaisie, Hazem"

PubPharm (16)

1

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K

enthalten in: Annals of hematology | 2021

von Mian, A. | Haberbosch, I. | Khamaisie, H. | +10

2

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $

enthalten in: Annals of hematology | 2021

von Mian, A. | Haberbosch, I. | Khamaisie, H. | +10

3

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $

enthalten in: Annals of hematology | 2021

von Mian, A. | Haberbosch, I. | Khamaisie, H. | +10

4

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-$ ABL1^{T315I} $ and BCR-$ ABL1^{T315I-E255K} $

enthalten in: Annals of hematology | 2021

von Mian, A. | Haberbosch, I. | Khamaisie, H. | +10

5

Safety of herbal medicine use during chemotherapy in patients with ovarian cancer : a "bedside-to-bench" approach

enthalten in: Medical oncology (Northwood, London, England) | 2017

von Ben-Arye, E. | Lavie, O. | Samuels, N. | +4

6

Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a “bedside-to-bench” approach

enthalten in: Medical oncology | 2017

von Ben-Arye, E. | Lavie, O. | Samuels, N. | +4

7

Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a “bedside-to-bench” approach

enthalten in: Medical oncology | 2017

von Ben-Arye, E. | Lavie, O. | Samuels, N. | +4

8

Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential

enthalten in: Journal of Cancer | 2017

von Kidan, N. | Khamaisie, H. | Ruimi, N. | +5

9

Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines : an in-vitro study

enthalten in: BMC cancer | 2016

von Ratzon, E. | Najajreh, Y. | Salem, R. | +3

10

Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study

enthalten in: BMC cancer | 2016

von Ratzon, E. | Najajreh, Y. | Salem, R. | +3